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Introduction  
Since the ban of most polybrominated diphenyl ethers (PBDEs) the production pattern of flame retardants has 
changed and alternatives are increasingly being used. These are generally described as novel brominated flame 
retardants (NBFRs) and include e.g. EH-TBB and BEH-TEBP in Firemaster 550®, which is one of the PentaBDE 
replacement products. However, little is known about exposure pathways, not least dermal absorption, for NBFRs 
and other POPs. Several studies have shown that for PBDEs dust is a significant exposure pathway1,2, similar can 
be expected for NBFRs. Positive correlations between PBDEs in dust, serum and handwipes have been reported3, 
but whether it is due to hand-to-mouth behavior or dermal absorption is unknown. Similarly, a positive correlation 
of EHTBB and BEH-TEBP in dust and hand-wipes of children was found4. 
The aim of the current study was to estimate the extent of dermal transport of NBFRs and determine the rate of the 
transport, which can be used in exposure scenarios. This is done using an ex vivo human skin model.  
 
Materials and methods 
Franz’ diffusion cells were used to study the percutaneous penetration of NBFRs. The system has previously been 
used for pesticide evaluation5 and consists of two half-cells as shown in Figure 1. A full thickness human skin 
sample dividing the two cells was mounted horizontally on a metal grid on the receptor chamber. A clamp kept the 
two half-cells together and held the skin in place at the same time. The cells were kept in a water bath at 34-38ºC 
ensuring a skin surface temperature close to 32ºC. The mean diffusion area was 2.64 cm2/cell and the mean 
receptor chamber volume 16.6 ml. Human skin was sampled from three female donors (age 38-41y) that 
underwent plastic surgery. The donors were given complete anonymity and only registered according to age, 
gender, date of operation, skin region, and size of skin patch. Skin samples were kept at -20 ºC for periods not 
exceeding nine months. This has proven to keep the barrier properties of the skin and no significant change in the 
water permeability6. The skin was allowed to thaw at room temperature before removal of subcutaneous fat and 
mounting in the diffusion cells. Full-thickness skin with an average thickness of 0.4 - 0.8 mm was used. Two types 
of receptor fluids were used: a physiological relevant receptor fluid (PHY) consisting of an aqueous solution of 
0.9% NaCl, 5% bovine serum albumin, 40 mg/l hexamycin and Na2HPO4 (pH 7.4); and a worst-case receptor fluid 
(WOC) consisting of 50% ethanol in water, which is known to increase skin permeability significantly7. After 
mounting, 5 ml isotonic saline was added to the donor chamber and left overnight for hydration of the skin. Before 
starting experiments the skin integrity was checked by measuring the capacitance (Lutron DM-9023, Acer AB, 
Sweden), which should not exceed 55 nF. After ensuring the integrity of the skin, the saline was removed and the 
NBFR were added to the donor chamber in 500 µl ethanol (with 20% isooctane residue). The cells were covered 
with parafilm and left in the waterbath with individual magnetic stirring for 72 hr.  
 
The experiment was terminated, and the residue in the donor chamber was collected by gently drying the skin 
using cotton swabs, followed by a gentle wash of skin and donor chamber with hexane soaked cotton swabs, and 
then again gentle wiping of the skin with dry cotton swabs. Afterwards saline was again added and the capacitance 
measured once again, it should not exceed 100 nF. The saline was discarded and the cells were dismounted. The 
entire volume of receptor fluid was sampled, and the chamber was rinsed with approximately 1 ml of fresh 
receptor fluid. The epidermis was scraped off the skin using a surgery knife, and of the remaining dermis-fraction 
the exposed part was separated from the surrounding tissue using scissors. 
 
 
Figure 1. Schematic of the experimental setup. Modified from OECD test guideline 4288. 
 
The samples were analysed for decabromodiphenyl ethane  (DBDPE), 1,2-bis(4,2,4-tribromophenoxy) ethane 
(BTBPE), 2,3-dibromopropyl-2,4,6-tribromophenyl ether (DPTE), 2-ethylhehexyl-2,3,4,5-tetrabromobenzoate 
(EH-TBB also known as TBB), bis(2-ethylhexyl)-3,4,5,6-tetrabromophthalate (BEH-TEBP also known as TBPH) 
as well as α, β and γ-HBCD in the following way. Donor chamber (D), epidermis (E) and dermis (H)-samples were 
extracted using ultrasonication with 10ml hexane:dichloromethane (1:1) two times for 30min. The extracts were 
evaporated and cleaned up on a glass column packed with 2g Al2O3 (10% H2O), 2g silica and Na2SO4 and eluted 
with 60ml hexane: dichloromethane (1:1). However, some dermis samples contained lipid residues and required 
further clean-up. This followed the H2SO4 containing column clean-up previously used for NBFRs in biota9, with 
the exception that the alternative gel permeation chromatography clean-up was not applied and therefore, 
BEH-TEBP was lost. The receptor fluid was extracted using Soxhlet extraction as described for PBDEs10, 
followed by the simple column clean-up described above. DBDPE, BTBPE, DPTE, EH-TBB and BEH-TEBP 
were analysed by GC-MS (ECNI) while HBCDs were analysed by LC-MS-MS.  
The distribution in the different compartments was calculated as the measured mass in the compartment relative to 
the total mass measured in the cell, the average of n cells is given in Table 1 and 2. The total absorbable is the sum 
of E, H, and R relative to the total mass in each cell. The mass recovery was calculated as the total mass measured 
in each cell relative to “archive spikes” (triplicates), which were merely 1 ml flasks spiked with the test solution at 
the same time as the cells, internal standards were added and they were analysed along with the samples. The flux 
was calculated for the individual cells as: 
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Since the flux in depending on concentration a compound specific a pseudo permeability coefficient, Kp,pse, which 
is based on the time averaged flux, was calculated as: 
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Results and discussion 
The preliminary results of the distribution of NBFRs and HBCDs between the compartments for physiological and 
worst-case receptor fluids are shown in Table 1 and 2, respectively. The overall mass recoveries in the experiments 
were close to 100% (±20%). The majority of the added amount was recovered in the donor chamber (76-92%) 
after 72 hr in both experiments, and only very little or nothing was found in the receptor fluid. Within the skin, the 
majority was found in the epidermis and only a smaller fraction in dermis. However, when using the worst-case 
receptor fluid a larger fraction seem to reach dermis, at least for the smaller compounds like DPTE (Table 2). 
Based on the fractional absorption the observed difference between the compounds is relatively small but with 
DPTE having the highest fraction absorbed. However, fractional absorption can depend on the applied dose (if the 
transport is flux-limited), resulting in larger fractional absorption at lower doses11; thus with the different doses of 
the compounds it can be misleading to compare in this way (Table 1 and 2). However, the flux is depending on 
concentration in the test solution. Therefore, the compound-specific pseudo permeability coefficient, Kp,pse is more 
convenient for comparing compounds (Table 3 and Figure 2).  
  
Table 1. Average distribution of NBFRs and HBCDs between compartments in skin penetration experiments using 
a physiological receptor fluid (PHY) (n=2). 
 
Load 
(ng/cm2) Receptor Dermis 
Epi- 
dermis Donor 
Total 
absorbable 
Mass 
recovery 
Flux72 hr  
(ng cm-2 hr-1) 
DPTE 3.79 0.52% 1.5% 11% 87% 15% 111% 0.0066 
EHTBB 15.0 0.24% 0.8% 11% 88% 11% 88% 0.0224 
BTBPE 14.9 0.10% 0.8% 11% 89% 11% 94% 0.0212 
BEH-TEBP 37.2 0.08% 0.6% 12% 88% 12% 98% 0.0500 
DBDPE 18.6 0.00% 0.4% 7% 92% 9% 116% 0.0154 
α-HBCD 4.46 0.15% 1.5% 12% 87% 13% 97% 0.0068 
β-HBCD 4.46 0.17% 1.3% 12% 86% 13% 96% 0.0066 
ϒ-HBCD 4.42 0.13% 1.3% 11% 87% 11% 88% 0.0058 
 
 
Table 2. Average distribution of NBFRs between compartments in skin penetration experiment using a 
“worst-case” (WOC) receptor fluid of 50% ethanol in water (n=6). Analysis of HBCDs in progress. 
 
Load 
(ng/cm2) Receptor Dermis 
Epi- 
dermis Donor 
Total 
absorbable 
Mass 
recovery 
Flux72 hr  
(ng cm-2 hr-1) 
DPTE 18.6 0.29% 11% 12% 76% 23% 97% 0.056 
EHTBB 44.7 0% 3% 11% 85% 13% 91% 0.074 
BTBPE 44.6 0.05% 3% 10% 88% 11% 94% 0.064 
BEH-TEBP 112 0% n.a. 9% 91% ≥ 7% 86% ≥ 0.122 
DBDPE 55.7 0% 2% 11% 87% 11% 83% 0.045 
n.a. Not available (see Materials and methods), if estimated from the mass recovery this fraction can be up to 14%. As a result, 
total absorbable and flux may be higher.  
 
 
While DPTE was observed to have the highest fractional absorption it had one of the lowest fluxes in the 
experiment and the largest flux was observed for BEH-TEBP followed by DBDPE, which had the lowest 
fractional absorptions. When comparing Kp,pse, DPTE had the highest value, indicating faster transport.  
 
The correlation between log Kow (Table 3) and Kp,pse is shown in Figure 2. For both types of receptor fluid, the rate 
of permeation is clearly decreasing with increasing log Kow. The effect of the worst case receptor fluid seems only 
to have an effect on the compounds with the lowest log Kow (DPTE).  
 
 
Table 3. Physical-chemical properties and pseudo 
permeability coefficients Kp,pse of NBFRs. 
 
 
MW 
(g/mol) 
log Kow12 
 
Kp,pse 
(PHY) 
(µm/h) 
Kp,pse 
(WOC) 
(µm/h) 
DPTE 530.7 5.8 3.3 5.7 
EHTBB 549.9 7.7 2.8 3.1 
BTBPE 687.6 8.3 2.5 2.1 
BEH-TEBP 706.2 9.3 2.7 2.7 
DBDPE 971.2 11.1 1.6 1.5 
α-HBCD 641.7 7.9 2.9 n.a. 
β-HBCD 641.7 7.9 2.8 n.a. 
ϒ-HBCD 641.7 7.9 2.5 n.a. 
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Figure 2. Pseudo permeability coefficient, Kp,pse as a 
function of log Kow. 
 
Only a few other studies on dermal uptake of BFRs have been published. Hughes et al (2001)13 measured dermal 
absorption of BDE-209 in mouse skin mounted in flow-through cells, and found that the fractional absorption 
depended on the dose. Pawar et al (2014)14 used reconstructed epidermis to estimate the dermal permeability of 
EHTBB and BEH-TEBP. In agreement with our study, they did not find BEH-TEBP in the receptor fluid within 
the duration of the experiment in spite of doses up to 200 times higher than in the present study.  
 
The human ex vivo skin model can be used to estimate dermal uptake of NBFRs. We have shown that for lipophilic 
compounds like NBFRs the skin depot is more important than the transfer to the receptor fluid. The skin depot has 
the potential for delayed systemic uptake in vivo. One of the advantages of the model is that the skin is stable for 
longer periods allowing experiments to run up to 72 hr, which is important for heavy, lipophilic compounds with 
long lag times.  
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